Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Beyond ICANS: A Pharmacovigilance Study on Neurotoxicity Related to Bispecific Antibodies in Multiple Myeloma

MM - 1510

Beyond ICANS: A Pharmacovigilance Study on Neurotoxicity Related to Bispecific Antibodies in Multiple Myeloma

Syed Maaz Tariq

Poster Presenter: Syed Maaz Tariq

Thumbnail for Real-World Overall Survival, Richter's Transformation, and Secondary Primary Malignancy Rates in CLL being treated with Fixed-Duration Venetoclax-Based Therapy vs. Indefinite BTK Inhibitor Monotherapy: A TriNetX Propensity-Matched Analysis

CLL - 1511

Real-World Overall Survival, Richter's Transformation, and Secondary Primary Malignancy Rates in CLL being treated with Fixed-Duration Venetoclax-Based Therapy vs. Indefinite BTK Inhibitor Monotherapy: A TriNetX Propensity-Matched Analysis

Avi Harisingani

Poster Presenter: Avi Harisingani

Previous 1...121 122 123 124 125 126 127...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Second Primary Malignancies in Plasma Cell Leukemia: A Retrospective Population-Based Analysis

MM - 1513

Second Primary Malignancies in Plasma Cell Leukemia: A Retrospective Population-Based Analysis

Michael Asare

Poster Presenter: Michael Asare

Thumbnail for Divergent Nodal and Extranodal Non-Hodgkin Lymphoma Latency Patterns Following Breast Cancer by Molecular Subtype: A Population-Based SEER Analysis

ABCL - 1515

Divergent Nodal and Extranodal Non-Hodgkin Lymphoma Latency Patterns Following Breast Cancer by Molecular Subtype: A Population-Based SEER Analysis

Maryam Ali

Poster Presenter: Maryam Ali

$Thumbnail for Phase III Randomized Evidence for BCMA-Directed CAR T-Cell Therapy Versus Standard Regimens in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 1517

Phase III Randomized Evidence for BCMA-Directed CAR T-Cell Therapy Versus Standard Regimens in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Vasu Malhotra

Poster Presenter: Vasu Malhotra

Thumbnail for Efficacy and Safety of Daratumumab-Added Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 1518

Efficacy and Safety of Daratumumab-Added Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis

Deepika Reddy Aluru

Poster Presenter: Deepika Reddy Aluru

Thumbnail for Community CARs - The Experience of a Community, Non-Hospital-Based Outpatient Cellular Therapy Program

CT - 1519

Community CARs - The Experience of a Community, Non-Hospital-Based Outpatient Cellular Therapy Program

Michael Byrne

Poster Presenter: Michael Byrne

Thumbnail for Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

MM - 1520

Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

Haroon Alamy

Poster Presenter: Haroon Alamy

Thumbnail for Disseminated Intravascular Coagulation in Adults with Active Acute Promyelocytic Leukemia: A Nationwide Analysis of Demographics, Comorbidities, Complications, and 30-Day Readmission Rates

AML - 1521

Disseminated Intravascular Coagulation in Adults with Active Acute Promyelocytic Leukemia: A Nationwide Analysis of Demographics, Comorbidities, Complications, and 30-Day Readmission Rates

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors